Chelation of Theranostic Copper Radioisotopes with S-Rich Macrocycles: From Radiolabelling of Copper-64 to In Vivo Investigation.
cancer
chelators
copper-64
radiopharmaceuticals
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
28 Jun 2022
28 Jun 2022
Historique:
received:
13
06
2022
revised:
21
06
2022
accepted:
22
06
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
14
7
2022
Statut:
epublish
Résumé
Copper radioisotopes are generally employed for cancer imaging and therapy when firmly coordinated via a chelating agent coupled to a tumor-seeking vector. However, the biologically triggered Cu
Identifiants
pubmed: 35807404
pii: molecules27134158
doi: 10.3390/molecules27134158
pmc: PMC9268100
pii:
doi:
Substances chimiques
Chelating Agents
0
Copper Radioisotopes
0
Radiopharmaceuticals
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Nucl Med. 2011 Jul;52(7):1110-8
pubmed: 21680701
Inorg Chem. 2021 Aug 2;60(15):11530-11547
pubmed: 34279088
Acc Chem Res. 2009 Jul 21;42(7):832-41
pubmed: 19530674
Bioconjug Chem. 2000 Jul-Aug;11(4):527-32
pubmed: 10898574
Curr Pharm Des. 2007;13(1):3-16
pubmed: 17266585
Front Biosci (Landmark Ed). 2009 Jun 01;14(13):4878-903
pubmed: 19482593
J Labelled Comp Radiopharm. 2014 Apr;57(4):224-30
pubmed: 24347474
Molecules. 2018 Sep 24;23(10):
pubmed: 30249975
Chem Soc Rev. 2014 Jan 7;43(1):260-90
pubmed: 24173525
Nucl Med Biol. 2014 May;41 Suppl:e49-57
pubmed: 24440584
Dalton Trans. 2016 May 7;45(17):7406-20
pubmed: 27041505
Inorg Chem. 2018 Mar 19;57(6):3061-3072
pubmed: 29488748
Org Biomol Chem. 2017 Feb 7;15(6):1475-1483
pubmed: 28116378
Nat Protoc. 2006;1(6):3062-8
pubmed: 17406569
ChemMedChem. 2015 Jul;10(7):1200-8
pubmed: 26011290
Bioconjug Chem. 2011 Aug 17;22(8):1729-35
pubmed: 21761921
Inorg Chem. 2017 Nov 20;56(22):13801-13814
pubmed: 29112419
Nucl Med Biol. 1998 Aug;25(6):523-30
pubmed: 9751418
Chem Rev. 2010 May 12;110(5):2858-902
pubmed: 20415480
J Biol Inorg Chem. 2016 Apr;21(2):177-84
pubmed: 26666778
Inorg Chem. 2014 May 19;53(10):5269-79
pubmed: 24758339
Nucl Med Biol. 1996 Nov;23(8):957-80
pubmed: 9004284
J Labelled Comp Radiopharm. 2019 Jun 30;62(8):460-470
pubmed: 30916408
Inorg Chem. 2017 Oct 2;56(19):11738-11752
pubmed: 28915014
Dalton Trans. 2020 Oct 20;49(40):14088-14098
pubmed: 32970072
Inorg Chem. 2020 Aug 17;59(16):11736-11748
pubmed: 32799456
EJNMMI Radiopharm Chem. 2021 Jan 13;6(1):3
pubmed: 33438075
Nucl Med Biol. 2012 Nov;39(8):1099-104
pubmed: 22743158
J Nucl Med. 2011 Aug;52(8):1276-84
pubmed: 21764795
Nucl Med Biol. 2011 Jan;38(1):29-38
pubmed: 21220127
J Labelled Comp Radiopharm. 2018 Jul;61(9):652-671
pubmed: 29230857
Bioconjug Chem. 2012 May 16;23(5):1029-39
pubmed: 22471317
Nucl Med Biol. 2000 May;27(4):375-80
pubmed: 10938473
Inorg Chem. 2020 Aug 3;59(15):10907-10919
pubmed: 32658468
J Biol Inorg Chem. 2003 Jan;8(1-2):217-25
pubmed: 12459917
Q J Nucl Med Mol Imaging. 2008 Jun;52(2):185-92
pubmed: 18043536
J Med Chem. 2002 Jan 17;45(2):469-77
pubmed: 11784151
J Med Chem. 2004 Mar 11;47(6):1465-74
pubmed: 14998334
Chem Commun (Camb). 2013 May 25;49(42):4720-39
pubmed: 23599005
PLoS One. 2018 Apr 18;13(4):e0195802
pubmed: 29668724